These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38553338)

  • 41. Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia.
    Bevilacqua M; De Marco L; Stupia R; Dima F; Cattazzo F; Paon V; Ieluzzi D; Dalbeni A; Sacerdoti D
    Intern Emerg Med; 2023 Aug; 18(5):1397-1404. PubMed ID: 37212944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis.
    Chen C; Yuan Z; Li W; Fei L; Ji L; Huang Q; Zhang S; Chen L
    Adv Ther; 2023 Mar; 40(3):1171-1186. PubMed ID: 36652176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.
    Balcar L; Krawanja J; Scheiner B; Paternostro R; Simbrunner B; Semmler G; Jachs M; Hartl L; Stättermayer AF; Schwabl P; Pinter M; Szekeres T; Trauner M; Reiberger T; Mandorfer M
    JHEP Rep; 2023 Apr; 5(4):100682. PubMed ID: 36873421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis.
    Saxena V; Nyberg L; Pauly M; Dasgupta A; Nyberg A; Piasecki B; Winston B; Redd J; Ready J; Terrault NA
    Hepatology; 2015 Sep; 62(3):715-25. PubMed ID: 26033798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression.
    Ishikawa T; Ichida T; Sugahara S; Yamagiwa S; Matsuda Y; Uehara K; Kato T; Miyazaki H; Asakura H
    Hepatol Res; 2002 Jun; 23(2):115-121. PubMed ID: 12048065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF.
    Blasi A; Patel VC; Adelmeijer J; Azarian S; Aziz F; Fernández J; Bernal W; Lisman T
    JHEP Rep; 2019 Sep; 1(3):179-187. PubMed ID: 32039368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
    Weiss N; Rosselli M; Mouri S; Galanaud D; Puybasset L; Agarwal B; Thabut D; Jalan R
    Metab Brain Dis; 2017 Apr; 32(2):369-376. PubMed ID: 27730496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward.
    Barosa R; Roque Ramos L; Patita M; Nunes G; Fonseca J
    Rev Esp Enferm Dig; 2017 Jun; 109(6):399-405. PubMed ID: 28467096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis.
    López-Vicario C; Checa A; Urdangarin A; Aguilar F; Alcaraz-Quiles J; Caraceni P; Amorós A; Pavesi M; Gómez-Cabrero D; Trebicka J; Oettl K; Moreau R; Planell N; Arroyo V; Wheelock CE; Clària J
    J Hepatol; 2020 Oct; 73(4):817-828. PubMed ID: 32294533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
    Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
    Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis.
    Dultz G; Seelhof M; Herrmann E; Welker MW; Friedrich-Rust M; Teuber G; Kronenberger B; von Wagner M; Vermehren J; Sarrazin C; Zeuzem S; Hofmann WP
    PLoS One; 2013; 8(8):e71262. PubMed ID: 23936497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of hemostatic profile in patients with mild to advanced liver cirrhosis.
    Adam EH; Möhlmann M; Herrmann E; Schneider S; Zacharowski K; Zeuzem S; Weber CF; Weiler N
    World J Gastroenterol; 2020 May; 26(17):2097-2110. PubMed ID: 32536777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
    Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Stättermayer AF; Semmler G; Pinter M; Ay C; Quehenberger P; Trauner M; Reiberger T; Lisman T; Mandorfer M
    J Hepatol; 2022 May; 76(5):1090-1099. PubMed ID: 35066090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortality.
    Jansen C; Chatterjee DA; Thomsen KL; Al-Kassou B; Sawhney R; Jones H; Gallego-Leon A; Lehmann J; Pohlmann A; Nickenig G; Strassburg CP; Andrié R; Jalan R; Linhart M; Trebicka J; Mookerjee RP
    Aliment Pharmacol Ther; 2019 Sep; 50(5):568-579. PubMed ID: 31286545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study.
    Tapper EB; Zhang P; Garg R; Nault T; Leary K; Krishnamurthy V; Su GL
    JHEP Rep; 2020 Feb; 2(1):100061. PubMed ID: 32039402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study.
    Pompili E; Baldassarre M; Bedogni G; Zaccherini G; Iannone G; De Venuto C; Pratelli D; Palmese F; Domenicali M; Caraceni P
    Liver Int; 2024 Jan; 44(1):72-82. PubMed ID: 37718730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute-on-chronic liver failure exists in patients with hepatitis B virus-related decompensated cirrhosis.
    Wang SJ; Yin S; Gu WY; Zhang Y; Li H
    J Dig Dis; 2018 Oct; 19(10):614-625. PubMed ID: 30226019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?
    Fragaki M; Sifaki-Pistolla D; Orfanoudaki E; Kouroumalis E
    Ann Gastroenterol; 2019; 32(6):626-632. PubMed ID: 31700241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of the CLIF-C OF and the 2016 MELD in Prognosis of Cirrhosis with and without Acute-on-Chronic Liver Failure.
    Perdigoto DN; Figueiredo P; Tomé L
    Ann Hepatol; 2019; 18(1):48-57. PubMed ID: 31113608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.